Pfizer Inc.PFENYSE
Loading
EV to Sales HistoryFair Value
Percentile Rank14
3Y CAGR+1.2%
5Y CAGR-10.5%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
+1.2%/yr
vs -11.7%/yr prior
5Y CAGR
-10.5%/yr
Recent acceleration
Acceleration
+12.9pp
Accelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 3.32 | -2.3% |
| 2024 | 3.40 | -12.2% |
| 2023 | 3.87 | +20.7% |
| 2022 | 3.21 | -28.7% |
| 2021 | 4.50 | -22.2% |
| 2020 | 5.79 | -7.2% |
| 2019 | 6.23 | +17.9% |
| 2018 | 5.29 | +12.8% |
| 2017 | 4.69 | +9.5% |
| 2016 | 4.28 | - |